Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer
IntroductionThe efficacy of immune checkpoint inhibitors (ICIs) is heterogeneous at each metastatic site, and tumor progression pattern is associated with survival; however, it remains unclear in gastric cancer (GC). Therefore, we aimed to clarify the progression pattern in response to ICIs in patie...
Main Authors: | Iori Motoo, Takayuki Ando, Takeru Hamashima, Shinya Kajiura, Miho Sakumura, Yuko Ueda, Aiko Murayama, Kohei Ogawa, Kenichiro Tsukada, Akira Ueda, Nobuhiro Suzuki, Naokatsu Nakada, Koji Nakashima, Ayumu Hosokawa, Ichiro Yasuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1193533/full |
Similar Items
-
Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea
by: Miho Sakumura, et al.
Published: (2020-10-01) -
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
by: Takayuki Ando, et al.
Published: (2015-01-01) -
Intensive surveillance endoscopy for multiple gastrointestinal tumors in a patient with constitutional mismatch repair deficiency: case report
by: Takayuki Ando, et al.
Published: (2021-08-01) -
Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Kohei Ogawa, et al.
Published: (2012-01-01) -
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
by: Aiko Murayama, et al.
Published: (2021-07-01)